参考文献/References:
[1] 刘道佳, 唐明灯, 林端瑜, 等. 18F-FDG与18F-FLT PET/CT诊断脑胶质瘤综合治疗后复发的对比研究[J]. 中华核医学与分子影像杂志, 2017, 37 (4):198-201. DOI:10.3760/cma.j.issn.2095-2848. 2017.04.002 Liu DJ, Tang MD, Lin DY, et al. Comparison on the diagnostic values of 18F-FDG and 18F-FLT PET/CT in patients with suspicious recurrence of glioma after multimodal treatment[J]. Chin J Nucl Med Mol Imaging, 2017, 37 (4):198-201.
[2] Kamiya-Matsuoka C, Gilbert MR. Treating recurrent glioblastoma:an update[J]. CNS Oncol, 2015, 4 (2):91-104. DOI:10.2217/cns.14.55.
[3] Santra A, Kumar R, Sharma P, et al. F-18 FDG PET-CT for predicting survival in patients with recurrent glioma:a prospective study[J]. Neuroradiology, 2011, 53 (12):1017-1024. DOI:10.1007/s00234-011-0898-3.
[4] Thiele F, Ehmer J, Piroth MD, et al. The quantification of dynamic FET PET imaging and correlation with the clinical outcome in patients with glioblastoma[J]. Phys Med Biol, 2009, 54 (18):5525-5539. DOI:10.1088/0031-9155/54/18/012.
[5] Karunanithi S, Sharma P, Kumar A, et al. Can 18F-FDOPA PET/CT predict survival in patients with suspected recurrent glioma? A prospective study[J]. Eur J Radiol, 2014, 83 (1):219-225. DOI:10.1016/j.ejrad.2013.09.004.
[6] Yamamoto Y, Ono Y, Aga F, et al. Correlation of 18F-FLT uptake with tumor grade and Ki-67 immunohistochemistry in patients with newly diagnosed and recurrent gliomas[J]. J Nucl Med, 2012, 53 (12):1911-1915. DOI:10.2967/jnumed.112.104729.
[7] Schwarzenberg J, Czernin J, Cloughesy TF, et al. 3’-deoxy-3’-18F-fluorothymidine PET and MRI for early survival predictions in patients with recurrent malignant glioma treated with bevacizumab[J]. J Nucl Med, 2012, 53 (1):29-36. DOI:10.2967/jnumed.111. 092387.
[8] Schiepers C, Dahlbom M, Chen W, et al. Kinetics of 3’-deoxy-3’-18F-fluorothymidine during treatment monitoring of recurrent high-grade glioma[J]. J Nucl Med, 2010, 51 (5):720-727. DOI:10.2967/jnumed.109068361.
[9] Idema AJ, Hoffmann AL, Boogaarts HD, et al. 3’-Deoxy-3’-18F-fluorothymidine PET-derived proliferative volume predicts overall survival in high-grade glioma patients[J]. J Nucl Med, 2012, 53 (12):1904-1910. DOI:10.2967/jnumed.112.105544.
[10] 董烨, 吴湖炳, 王全师, 等. 18F-FDG PET/CT多次显像在监测和预测非小细胞肺癌术后复发和转移中的价值[J]. 中华核医学与分子影像学杂志, 2014, 34 (2):81-85. DOI:10.3760/cma.j.issn.2095-2848.2014.02.001. Dong Y, Wu HB, Wang QS, et al. Prediction of postoperative recurrence and metastasis with 18F-FDG PET/CT in patients with non-small cell lung cancer[J]. Chin J Nucl Med Mol Imaging, 2014, 34 (2):81-85.
[11] 谢彦婷, 郑容. 18F-FDG PET/CT在食管癌放疗中的应用[J]. 国际放射医学核医学杂志, 2013, 37 (1):42-46. DOI:10.3760/cma.j.issn.1673-4114.2013.01.012. Xie YT, Zheng R. The application of 18F-FDG PET/CT in the radiotherapy of esophageal cancer[J]. Int J Radiat Med Nucl Med, 2013, 37 (1):42-46.
[12] 陈丹丹, 吴湖炳, 王全师, 等. 18F-FDG PET/CT在复发宫颈癌疗效评价及预后预测中的价值[J]. 中华核医学与分子影像学杂志, 2015, 35 (3):168-172. DOI:10.3760/cma.j.issn.2095-2848. 2015. 03.003. Chen DD, Wu HB, Wang QS, et al. Value of 18F-FDG PET/CT in the evaluation of treatment response and prognosis for patients with recurrent uterine cervical cancer[J]. Chin J Nucl Med Mol Imaging, 2015, 35 (3):168-172.
[13] 戴云秀, 杨光杰, 王振光, 等. 18F-FDG PET/CT基线SUVmax在滤泡性淋巴瘤侵袭性、分期评价中的价值及其与中期疗效的相关性研究[J]. 国际放射医学核医学杂志, 2018, 42 (2):104-110. DOI:10.3760/cma.j.issn.1673-4114.2018.02.002. Dai YX, Yang GJ, Wang ZG, et al. Evaluation of invasiveness, staging, and correlation with interim therapeutic response based on baseline 18F-FDG PET/CT SUVmax in patients with follicular lymphoma[J]. Int J Radiat Med Nucl Med, 2018, 42 (2):104-110.
[14] Colavolpe C, Chinot O, Metellus P, et al. FDG-PET predicts survival in recurrent high-grade gliomas treated with bevacizumab and irinotecan[J]. Neuro Oncol, 2012, 14 (5):649-657. DOI:10.1093/neuonc/nos012.
相似文献/References:
[1]程勇军,赵晋华.东亚钳蝎氯毒素在胶质瘤靶向显像与治疗中的研究进展[J].国际放射医学核医学杂志,2015,39(1):32.[doi:10.3760/cma.j.issn.1673-4114.2015.01.008]
Cheng Yongjun,Zhao Jinhua.Development of research in targeting image and therapy of gliomas using Buthus martensii Karsch chlorotoxin[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):32.[doi:10.3760/cma.j.issn.1673-4114.2015.01.008]
[2]高艳,赵晋华.PET/MRI融合显像在脑胶质瘤诊断和治疗中的研究进展[J].国际放射医学核医学杂志,2015,39(1):71.[doi:10.3760/cma.j.issn.1673-4114.2015.01.015]
Gao Yan,Zhao Jinhua.The advancement of PET/MRI on the diagnosis and treatment of brain gliomas[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):71.[doi:10.3760/cma.j.issn.1673-4114.2015.01.015]
[3]周惠君,董萍,沈国华,等.11C-蛋氨酸PET/CT显像在脑胶质瘤中的应用价值[J].国际放射医学核医学杂志,2015,39(2):161.[doi:10.3760/cma.j.issn.1673-4114.2015.02.013]
Zhou Huijun,Dong Ping,Shen Guohua,et al.Value of 11C-methionine PET/CT imaging indiagnosing cerebral glioma[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):161.[doi:10.3760/cma.j.issn.1673-4114.2015.02.013]
[4]周新韩,高明勇,张仙海,等.磁敏感加权成像显示肿瘤内静脉评价胶质瘤分级[J].国际放射医学核医学杂志,2014,38(6):373.[doi:10.3760/cma.j.issn.1673-4114.2014.06.006]
Zhou Xin-han,Gao Ming-yong,Zhang Xian-hai,et al.Values of tumor vein detected by susceptibility weighted imaging in evaluation of gliomas grade[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):373.[doi:10.3760/cma.j.issn.1673-4114.2014.06.006]
[5]李平,宗天舟,季晓芹,等.CD133+U87人脑胶质瘤干细胞放射敏感性和DNA双链断裂损伤修复的实验研究[J].国际放射医学核医学杂志,2013,37(3):153.[doi:10.3760/cma.j.issn.1673-4114.2013.03.007]
LI Ping,ZONG Tian-zhou,JI Xiao-qin,et al.CD133 positive U87 glioma stem cell radiosensitivity and DNA double-strand break repair[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(5):153.[doi:10.3760/cma.j.issn.1673-4114.2013.03.007]
[6]展凤麟,汪世存,潘博,等.11C-胆碱和18F-FDG PET/CT显像在脑胶质瘤诊断中的应用[J].国际放射医学核医学杂志,2013,37(4):193.[doi:10.3760/cma.j.issn.1673-4114.2013.04.001]
ZHAN Feng-lin,WANG Shi-cun,PAN Bo,et al.Application of 11C-choline and 18F-FDG PET/CT in diagnosing brain glioma[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(5):193.[doi:10.3760/cma.j.issn.1673-4114.2013.04.001]
[7]李立芳,韩宝林.早期乳腺癌根治术后辅助放疗指征探讨[J].国际放射医学核医学杂志,2013,37(5):287.[doi:10.3760/cma.j.issn.1673-4114.2013.05.009]
LI Li-fang,HAN Bao-lin.Indications for postmastectomy radiotherapy in early breast cancer patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(5):287.[doi:10.3760/cma.j.issn.1673-4114.2013.05.009]
[8]王志军,许祖闪,丛英珍,等.高场强MRI与X线钡餐造影、胃镜诊断胃癌术后复发的对比分析[J].国际放射医学核医学杂志,2012,36(1):46.[doi:10.3760/cma.j.issn.1673-4114.2012.01.012]
WANG Zhi-jun,XU Zu-shan,CONG Ying-zhen,et al.The diagnosis of recurrent gastric carcinoma: high-field-strength MRI compared with barium meal of alimentary canal and gastroscope[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(5):46.[doi:10.3760/cma.j.issn.1673-4114.2012.01.012]
[9]李鹏,赵卫威,杨建伟.18F-FDG PET-CT在探测卵巢癌术后复发与转移中的应用价值[J].国际放射医学核医学杂志,2012,36(6):348.[doi:10.3760/cma.j.issn.1673-4114.2012.06.007]
LI Peng,ZHAO Wei-wei,YANG Jian-wei.18F-FDG PET-CT imaging in the detection of recurrent and metastasis ovarian cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(5):348.[doi:10.3760/cma.j.issn.1673-4114.2012.06.007]
[10]杨辉,张富强,李文亮,等.术中125Ⅰ粒子植入治疗复发性脑胶质瘤的临床研究[J].国际放射医学核医学杂志,2013,37(6):345.[doi:10.3760/cma.j.issn.1673-4114.2013.06.005]
YANG Hui,ZHANG Fu-qiang,LI Wen-liang,et al.Clinical study of operation combined with 125Ⅰ seeds implantation in the treatment of recurrent cerebral glioma[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(5):345.[doi:10.3760/cma.j.issn.1673-4114.2013.06.005]